Anuncio • Apr 03
K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026 K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026, at 10:00 W. Europe Standard Time. Anuncio • Mar 17
K+S Aktiengesellschaft to Report Fiscal Year 2026 Results on Mar 11, 2027 K+S Aktiengesellschaft announced that they will report fiscal year 2026 results at 7:00 AM, Central European Standard Time on Mar 11, 2027 Anuncio • Mar 13
K+S Aktiengesellschaft announces Annual dividend, payable on May 15, 2026 K+S Aktiengesellschaft announced Annual dividend of EUR 0.0700 per share payable on May 15, 2026, ex-date on May 13, 2026 and record date on May 14, 2026. Anuncio • Nov 17
K+S Aktiengesellschaft to Report Q3, 2026 Results on Nov 10, 2026 K+S Aktiengesellschaft announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Nov 10, 2026 Anuncio • Aug 15
K+S Aktiengesellschaft to Report Q2, 2026 Results on Aug 12, 2026 K+S Aktiengesellschaft announced that they will report Q2, 2026 results on Aug 12, 2026 Anuncio • May 15
K+S Aktiengesellschaft to Report Q1, 2026 Results on May 11, 2026 K+S Aktiengesellschaft announced that they will report Q1, 2026 results on May 11, 2026 Anuncio • Mar 15
K+S Aktiengesellschaft to Report Fiscal Year 2025 Results on Mar 12, 2026 K+S Aktiengesellschaft announced that they will report fiscal year 2025 results on Mar 12, 2026 Reported Earnings • Nov 16
Third quarter 2024 earnings: EPS and revenues exceed analyst expectations Third quarter 2024 results: €0.15 loss per share (improved from €0.26 loss in 3Q 2023). Revenue: €866.2m (down 1.7% from 3Q 2023). Net loss: €26.4m (loss narrowed 45% from 3Q 2023). Revenue exceeded analyst estimates by 4.4%. Earnings per share (EPS) also surpassed analyst estimates by 25%. Revenue is forecast to stay flat during the next 3 years compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance. Anuncio • Nov 15
K+S Aktiengesellschaft to Report Q3, 2025 Results on Nov 11, 2025 K+S Aktiengesellschaft announced that they will report Q3, 2025 results on Nov 11, 2025 Price Target Changed • Sep 09
Price target decreased by 7.7% to €13.25 Down from €14.35, the current price target is an average from 17 analysts. New target price is 28% above last closing price of €10.38. Stock is down 41% over the past year. The company is forecast to post earnings per share of €0.29 for next year compared to €1.12 last year. Price Target Changed • Aug 22
Price target decreased by 8.1% to €13.42 Down from €14.61, the current price target is an average from 17 analysts. New target price is 26% above last closing price of €10.70. Stock is down 37% over the past year. The company is forecast to post earnings per share of €0.29 for next year compared to €1.12 last year. Reported Earnings • Aug 15
Second quarter 2024 earnings: EPS and revenues exceed analyst expectations Second quarter 2024 results: €0.034 loss per share (improved from €0.24 loss in 2Q 2023). Revenue: €873.8m (up 5.8% from 2Q 2023). Net loss: €6.10m (loss narrowed 87% from 2Q 2023). Revenue exceeded analyst estimates by 9.3%. Earnings per share (EPS) also surpassed analyst estimates by 10%. Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Anuncio • Aug 14
K+S Aktiengesellschaft to Report Q2, 2025 Results on Aug 12, 2025 K+S Aktiengesellschaft announced that they will report Q2, 2025 results on Aug 12, 2025 Anuncio • May 14
K+S Aktiengesellschaft to Report Q1, 2025 Results on May 13, 2025 K+S Aktiengesellschaft announced that they will report Q1, 2025 results on May 13, 2025 Reported Earnings • May 13
First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind First quarter 2024 results: EPS: €0.10 (down from €1.38 in 1Q 2023). Revenue: €988.0m (down 17% from 1Q 2023). Net income: €18.6m (down 93% from 1Q 2023). Profit margin: 1.9% (down from 22% in 1Q 2023). Revenue exceeded analyst estimates by 7.1%. Earnings per share (EPS) missed analyst estimates by 64%. Revenue is forecast to grow 1.1% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 12% per year. Upcoming Dividend • May 09
Upcoming dividend of €0.70 per share Eligible shareholders must have bought the stock before 15 May 2024. Payment date: 17 May 2024. Payout ratio is a comfortable 62% and this is well supported by cash flows. Trailing yield: 5.1%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (4.9%). Declared Dividend • Mar 16
Dividend of €0.70 announced Shareholders will receive a dividend of €0.70. Ex-date: 15th May 2024 Payment date: 17th May 2024 Dividend yield will be 5.3%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (62% earnings payout ratio) and cash flows (37% cash payout ratio). The dividend has increased by an average of 11% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to decline by 65% over the next 3 years. Since a fall of 31% would increase the payout ratio to a potentially unsustainable range, the dividend may be at risk. Anuncio • Mar 15
K+S Aktiengesellschaft to Report Fiscal Year 2024 Results on Mar 13, 2025 K+S Aktiengesellschaft announced that they will report fiscal year 2024 results on Mar 13, 2025 Reported Earnings • Mar 15
Full year 2023 earnings: EPS exceeds analyst expectations Full year 2023 results: EPS: €1.12 (down from €7.88 in FY 2022). Revenue: €3.87b (down 32% from FY 2022). Net income: €209.9m (down 86% from FY 2022). Profit margin: 5.4% (down from 27% in FY 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 21%. Revenue is forecast to stay flat during the next 3 years compared to a 3.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth. New Risk • Nov 15
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 56% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 56% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (16% net profit margin). Anuncio • Aug 15
K+S Aktiengesellschaft to Report Q1, 2024 Results on May 13, 2024 K+S Aktiengesellschaft announced that they will report Q1, 2024 results at 7:00 AM, Central European Standard Time on May 13, 2024 Reported Earnings • Aug 13
Second quarter 2023 earnings: EPS misses analyst expectations Second quarter 2023 results: €0.24 loss per share (down from €1.94 profit in 2Q 2022). Revenue: €825.8m (down 45% from 2Q 2022). Net loss: €45.3m (down 112% from profit in 2Q 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 28%. Revenue is expected to decline by 4.1% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.0%. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth. Anuncio • Aug 11
K+S Aktiengesellschaft to Report Q2, 2024 Results on Aug 14, 2024 K+S Aktiengesellschaft announced that they will report Q2, 2024 results on Aug 14, 2024 Upcoming Dividend • May 04
Upcoming dividend of €1.00 per share at 5.8% yield Eligible shareholders must have bought the stock before 11 May 2023. Payment date: 15 May 2023. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (5.6%). Reported Earnings • Mar 16
Full year 2022 earnings: EPS exceeds analyst expectations Full year 2022 results: EPS: €7.88 (down from €11.35 in FY 2021). Revenue: €5.68b (up 77% from FY 2021). Net income: €1.51b (down 31% from FY 2021). Profit margin: 27% (down from 68% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 18%. Revenue is expected to decline by 6.9% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.7%. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has only increased by 53% per year, which means it is significantly lagging earnings growth. Anuncio • Jan 27
K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH). K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH) on January 26, 2023. The new business will operate under the name Fertiva (Pty) Ltd. The balance of 25% of shares in Fertiva will be held by two former ICH shareholders, who will now be a part of the Fertiva management team. The closing of the transaction remains subject to the fulfillment of a number of conditions, including obtaining required regulatory approvals and is expected to close during the second quarter of 2023. Anuncio • Jan 22
K+S Aktiengesellschaft Appoints Carin-Martina Tröltzsch as Member of the Board of Executive Directors, Effective March 15, 2023 The Supervisory Board of K+S Aktiengesellschaft has appointed Dr. Carin-Martina Tröltzsch as a further member of the Board of Executive Directors of the Company. She will assume her position at K+S on March 15, 2023. Dr. Christian H. Meyer, who was already appointed as the new Chief Financial Officer by the Supervisory Board of the Company in February of last year, will also take up his position on March 15, 2023, and will be responsible for the management and further development of the finance area at K+S. Dr. Burkhard Lohr, Chairman of the Board of Executive Directors, had assumed this role on a transitional basis in recent months. Anuncio • Nov 13
K+S Aktiengesellschaft to Report Q3, 2022 Results on Nov 14, 2023 K+S Aktiengesellschaft announced that they will report Q3, 2022 results at 7:00 AM, Central European Standard Time on Nov 14, 2023 Reported Earnings • Aug 13
Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Second quarter 2022 results: EPS: €1.93 (up from €0.78 in 2Q 2021). Revenue: €1.51b (up 127% from 2Q 2021). Net income: €370.3m (up 147% from 2Q 2021). Profit margin: 25% (up from 23% in 2Q 2021). Revenue exceeded analyst estimates by 7.3%. Earnings per share (EPS) missed analyst estimates by 9.0%. Over the next year, revenue is forecast to grow 20%, compared to a 1.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Anuncio • Aug 12
K+S Aktiengesellschaft to Report Q2, 2023 Results on Aug 10, 2023 K+S Aktiengesellschaft announced that they will report Q2, 2023 results on Aug 10, 2023 Price Target Changed • Jun 24
Price target increased to €31.29 Up from €28.68, the current price target is an average from 14 analysts. New target price is 39% above last closing price of €22.50. Stock is up 96% over the past year. The company is forecast to post earnings per share of €8.26 for next year compared to €11.35 last year. Reported Earnings • May 13
First quarter 2022 earnings: Revenues miss analyst expectations First quarter 2022 results: Revenue: €1.21b (up 65% from 1Q 2021). Net income: €310.9m (up 44% from 1Q 2021). Profit margin: 26% (down from 29% in 1Q 2021). Revenue missed analyst estimates by 5.3%. Over the next year, revenue is forecast to grow 46%, compared to a 6.4% growth forecast for the industry in Germany. Anuncio • May 12
K+S Aktiengesellschaft to Report Q1, 2023 Results on May 09, 2023 K+S Aktiengesellschaft announced that they will report Q1, 2023 results on May 09, 2023 Upcoming Dividend • May 06
Upcoming dividend of €0.20 per share Eligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Trailing yield: 0.6%. Lower than top quartile of German dividend payers (4.1%). Lower than average of industry peers (5.1%). Valuation Update With 7 Day Price Move • Apr 11
Investor sentiment improved over the past week After last week's 16% share price gain to €32.38, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 81% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €35.42 per share. Price Target Changed • Apr 08
Price target increased to €26.21 Up from €23.56, the current price target is an average from 14 analysts. New target price is 12% below last closing price of €29.66. Stock is up 257% over the past year. The company is forecast to post earnings per share of €6.06 for next year compared to €11.35 last year. Buying Opportunity • Mar 30
Now 27% undervalued Over the last 90 days, the stock is up 70%. The fair value is estimated to be €35.17, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 4.6% per annum. Earnings is forecast to decline by 51% per annum over the same time period. Reported Earnings • Mar 11
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: EPS: €11.36 (up from €9.88 loss in FY 2020). Revenue: €3.21b (up 32% from FY 2020). Net income: €2.17b (up €4.06b from FY 2020). Profit margin: 68% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Revenue exceeded analyst estimates by 2.3%. Earnings per share (EPS) also surpassed analyst estimates by 31%. Over the next year, revenue is forecast to grow 28%, compared to a 4.8% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 12% per year. Reported Earnings • Mar 11
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: EPS: €11.36 (up from €9.88 loss in FY 2020). Revenue: €3.21b (up 32% from FY 2020). Net income: €2.17b (up €4.06b from FY 2020). Profit margin: 68% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Revenue exceeded analyst estimates by 2.3%. Earnings per share (EPS) also surpassed analyst estimates by 31%. Over the next year, revenue is forecast to grow 28%, compared to a 4.8% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 12% per year. Price Target Changed • Mar 08
Price target increased to €18.92 Up from €17.59, the current price target is an average from 17 analysts. New target price is 19% below last closing price of €23.30. Stock is up 135% over the past year. The company is forecast to post earnings per share of €11.83 next year compared to a net loss per share of €9.88 last year. Buying Opportunity • Feb 22
Now 21% undervalued Over the last 90 days, the stock is up 24%. The fair value is estimated to be €24.44, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 24% per annum over the last 3 years. The company has become profitable over the last year. Price Target Changed • Nov 17
Price target increased to €15.32 Up from €14.27, the current price target is an average from 18 analysts. New target price is approximately in line with last closing price of €14.65. Stock is up 112% over the past year. The company is forecast to post earnings per share of €8.75 next year compared to a net loss per share of €9.88 last year. Reported Earnings • Nov 15
Third quarter 2021 earnings released: EPS €6.64 (vs €10.26 loss in 3Q 2020) Third quarter 2021 results: Revenue: €746.3m (down 9.2% from 3Q 2020). Net income: €1.27b (up €3.23b from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Price Target Changed • Sep 20
Price target increased to €12.75 Up from €11.88, the current price target is an average from 17 analysts. New target price is approximately in line with last closing price of €12.82. Stock is up 142% over the past year. Reported Earnings • Aug 18
Second quarter 2021 earnings released: EPS €0.78 (vs €0.019 loss in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €664.2m (up 13% from 2Q 2020). Net income: €149.9m (up €153.6m from 2Q 2020). Profit margin: 23% (up from net loss in 2Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 101 percentage points per year, which is a significant difference in performance. Price Target Changed • Aug 04
Price target increased to €11.88 Up from €11.02, the current price target is an average from 15 analysts. New target price is approximately in line with last closing price of €12.32. Stock is up 95% over the past year. Price Target Changed • Jul 21
Price target increased to €11.63 Up from €10.85, the current price target is an average from 16 analysts. New target price is approximately in line with last closing price of €11.89. Stock is up 92% over the past year. Price Target Changed • Jun 15
Price target increased to €10.86 Up from €10.13, the current price target is an average from 16 analysts. New target price is 9.5% below last closing price of €12.00. Stock is up 85% over the past year. Reported Earnings • May 14
First quarter 2021 earnings released: EPS €1.13 (vs €0.33 loss in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €733.3m (up 13% from 1Q 2020). Net income: €215.7m (up €278.9m from 1Q 2020). Profit margin: 29% (up from net loss in 1Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 105 percentage points per year, which is a significant difference in performance. Price Target Changed • May 12
Price target increased to €9.44 Up from €8.80, the current price target is an average from 16 analysts. New target price is 8.2% below last closing price of €10.28. Stock is up 95% over the past year. Price Target Changed • Mar 20
Price target decreased to €8.60 Down from €9.33, the current price target is an average from 14 analysts. New target price is approximately in line with last closing price of €8.55. Stock is up 54% over the past year. Price Target Changed • Mar 18
Price target decreased to €8.49 Down from €9.13, the current price target is an average from 14 analysts. New target price is approximately in line with last closing price of €8.55. Stock is up 46% over the past year. Is New 90 Day High Low • Jan 05
New 90-day high: €8.44 The company is up 18% from its price of €7.15 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.57 per share. Is New 90 Day High Low • Nov 25
New 90-day high: €7.25 The company is up 14% from its price of €6.38 on 26 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €21.76 per share. Reported Earnings • Nov 13
Third quarter 2020 earnings released: €10.26 loss per share The company reported a poor third quarter result with increased losses and weaker revenues and control over expenses. Third quarter 2020 results: Revenue: €821.7m (down 9.2% from 3Q 2019). Net loss: €1.96b (loss widened €1.91b from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 132% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings. Analyst Estimate Surprise Post Earnings • Nov 13
Earnings beat expectations, revenue disappoints Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) exceeded analyst estimates by 3,169%. Over the next year, revenue is forecast to grow 3.2%, compared to a 3.6% growth forecast for the Chemicals industry in Germany. Price Target Changed • Oct 06
Price target raised to €8.30 Up from €7.58, the current price target is an average from 20 analysts. The new target price is 18% above the current share price of €7.04. As of last close, the stock is down 42% over the past year. Is New 90 Day High Low • Sep 22
New 90-day low: €5.29 The company is down 9.0% from its price of €5.80 on 24 June 2020. The German market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €17.99 per share.